These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22559233)

  • 1. Erythropoietin, but not asialoerythropoietin or carbamyl-erythropoietin, attenuates monocrotaline-induced pulmonary hypertension in rats.
    Ikarashi N; Toba K; Kato K; Ozawa T; Oda M; Takayama T; Kobayashi H; Yanagawa T; Hanawa H; Suzuki T; Nakazawa M; Nomoto M; Asami F; Higuchi M; Saito H; Aizawa Y
    Clin Exp Hypertens; 2012; 34(8):575-81. PubMed ID: 22559233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
    King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
    Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
    Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.
    Grasso G; Sfacteria A; Erbayraktar S; Passalacqua M; Meli F; Gokmen N; Yilmaz O; La Torre D; Buemi M; Iacopino DG; Coleman T; Cerami A; Brines M; Tomasello F
    J Neurosurg Spine; 2006 Apr; 4(4):310-8. PubMed ID: 16619678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
    Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S
    Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of erythropoietin on advanced pulmonary vascular remodelling.
    van Albada ME; du Marchie Sarvaas GJ; Koster J; Houwertjes MC; Berger RM; Schoemaker RG
    Eur Respir J; 2008 Jan; 31(1):126-34. PubMed ID: 17898019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asialoerythropoietin exerts stronger angiogenic activity than erythropoietin via its binding affinity to tissue.
    Yanagawa T; Toba K; Kato K; Suzuki T; Minagawa S; Saigawa T; Ozawa T; Oda M; Takayama T; Hanawa H; Higuchi M; Saito H; Aizawa Y
    Cardiovasc Drugs Ther; 2013 Apr; 27(2):117-24. PubMed ID: 23314760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat.
    Mori S; Sawada T; Okada T; Kubota K
    Surgery; 2008 Apr; 143(4):556-65. PubMed ID: 18374054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
    Li X; Gonias SL; Campana WM
    Glia; 2005 Sep; 51(4):254-65. PubMed ID: 15812815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
    Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
    Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells.
    Yamasaki M; Mishima HK; Yamashita H; Kashiwagi K; Murata K; Minamoto A; Inaba T
    Brain Res; 2005 Jul; 1050(1-2):15-26. PubMed ID: 15979589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
    Fiordaliso F; Chimenti S; Staszewsky L; Bai A; Carlo E; Cuccovillo I; Doni M; Mengozzi M; Tonelli R; Ghezzi P; Coleman T; Brines M; Cerami A; Latini R
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2046-51. PubMed ID: 15671158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single injection of liposomal asialo-erythropoietin improves motor function deficit caused by cerebral ischemia/reperfusion.
    Ishii T; Asai T; Fukuta T; Oyama D; Yasuda N; Agato Y; Shimizu K; Minamino T; Oku N
    Int J Pharm; 2012 Dec; 439(1-2):269-74. PubMed ID: 22989979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures.
    Won YJ; Yoo JY; Lee JH; Hwang SJ; Kim D; Hong HN
    Brain Res; 2007 Jun; 1154():31-9. PubMed ID: 17493599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin downregulates bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury.
    Kumral A; Genc S; Ozer E; Yilmaz O; Gokmen N; Koroglu TF; Duman N; Genc K; Ozkan H
    Biol Neonate; 2006; 89(3):205-10. PubMed ID: 16319448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
    Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
    Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures.
    Yoo JY; Won YJ; Lee JH; Kim JU; Sung IY; Hwang SJ; Kim MJ; Hong HN
    J Neurosci Res; 2009 Jan; 87(1):150-63. PubMed ID: 18711747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
    Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.